I don’t think proteomics will win over genomics," Sanghera said. "They go hand-in-glove. We’ve been overly focused [on genomics], and now we’re going to see an emergence of proteomics. And when the ...

The programme will utilise Oxford Nanopore’s PromethION 48 sequencing devices. The National Precision Medicine (NPM) ...

View Full Profile. Learn about our Editorial Policies. What is the biggest difference between using nanopore technology for protein sequencing versus nucleic acid sequencing? Protein sequencing is a ...

UC Riverside scientists have developed a nanopore-based tool that could help diagnose illnesses much faster and with greater precision than current tests allow, by capturing signals from ...

Sales seem to have been boosted by the 55 per cent growth in its PromethION product, alongside new product launches in its mature market. However, the share price rise was somewhat confusing as Oxford ...

Nanopore sequencing overcomes these challenges, providing scientists and public health officials with a comprehensive, rapid, and cost-effective pathogen surveillance approach.

Shares in genomics sequencing company Oxford Nanopore were rising sharply this morning after it announced an £80 million ($102 million) share placement that included a £50 million investment ...

Coca-Cola bottler CCEP to change UK listing category with eye on FTSE 100 inclusion October 18, 2024 Shares in Britain's Oxford Nanopore dropped nearly 12% on Tuesday, after the sensing technology ...